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The stimulation of postprandial K + clearance involves aldosterone-independent anddependent mechanisms. In this context, SGK1, an ubiquitously expressed kinase, is one of the primary aldosterone induced proteins in the aldosterone sensitive distal nephron (ASDN).
Germline inactivation of SGK1 suggests that this kinase is fundamental for K + excretion under conditions of K + load, but the specific role of renal SGK1 remains elusive. To avoid compensatory mechanisms that may occur during nephrogenesis, we employed inducible, nephron-specific Sgk1 Pax8/LC1 mice to assess the role of renal-tubular SGK1 in K + regulation.
Under standard diet, these animals exhibited normal K + handling. When challenged by a high K + diet (HKD), they developed severe hyperkalemia, accompanied by a defect in K + excretion.
Molecular analysis revealed reduced NEDD4-2 phosphorylation and total expression. γENaC expression and α/γENaC proteolytic processing were also decreased in the mutant mice.
Moreover, WNK1, which displayed in control mice punctuate staining in the DCT and diffuse distribution in the CNT/CCD, was diffused in the DCT and less expressed in the CNT/CD of Sgk Pax8/LC1 mice. Moreover, SPAK phosphorylation, and NCC phosphorylation/apical localization were reduced in the mutant. Consistent with the altered WNK1 expression, increased ROMK apical localization was observed. In conclusion, our data suggest that renaltubular SGK1 is important in the regulation of K + excretion via the control of NEDD4-2, WNK1
and ENaC.
INTRODUCTION
Maintenance of plasma potassium (K + ) level within normal physiological range (3.5 to 5.0 mM) is crucial for proper function of excitable cells (e.g., neurons, skeletal and cardiac myocytes) and represents a significant homeostatic challenge that is mediated by the tight coordination of K + excretion via the kidney (and to a lesser extent colon), and K + storage occurring mainly in skeletal muscle (67) . It is well accepted that control of K + balance by the kidney involves both aldosterone-dependent and -independent mechanisms (55, 56, 64) . Renal K + secretion takes place essentially in the so-called aldosterone sensitive distal nephron (ASDN) as defined by Loffing et al. (35) . One of the most prominent proteins stimulated by aldosterone in the ASDN is the otherwise ubiquitously expressed serum-and glucocorticoidinduced kinase 1 (SGK1) (28, 34) . Studies performed in cellular and animal models suggest that SGK1 controls renal Na + reabsorption through regulation of the epithelial Na + channel
ENaC and Na + ,Cl --cotransporter NCC (3, 10, 17-19, 37, 65) . This involves phosphorylation of S222, S246 and S328 residues of the ubiquitin-protein ligase NEDD4-2 (5, 17, 52), known to ubiquitylate and negatively regulate ENaC and NCC (1, 3, 22, 26, 45, 51) . On the other hand, it has also been suggested that SGK1 acts via phosphorylation of WNK kinases (12, 44, 48 together with the involvement of the colon, the skeletal muscle and the liver in K + homeostasis, leave the possibility that the impaired ability of Sgk1 -/-mice to handle K + load was due to renal and extra-renal SGK1 (6, 29) .
To decipher the specific role of renal-tubular SGK1 in K + homeostasis, we took advantage of the previously described inducible, nephron specific Sgk1 Pax8/LC1 model (18) .
These mice showed a Na + losing phenotype when Na + supply was restricted, which correlated with decreased NCC and ENaC protein levels, and reduced NEDD4-2 phosphorylation (18).
Here, we show that even though SGK1 is expressed in several organs involved in K + homeostasis, the action of renal-tubular SGK1 is crucial for proper renal K + excretion and is mediated mainly by ENaC. Our data suggest that NEDD4-2 and WNK1 are key players in SGK1-mediated K + homeostasis. Protein lysates preparation and immunoblotting. Frozen tissues were homogenized using buffer containing TrisHCl 50mM, pH7.5, EDTA 1mM, EGTA 1mM, Sucrose 0.27M, NaF 50mM, Na-pyrophosphate 5mM in addition to protease inhibitors purchased from ROCHE (Complete Cat. #11836145001). Protein homogenates were then centrifuged at 10'000g for 10 min at 4°C, supernatant was collected and protein concentration was measured using the BradFord method (Uptima, Cat #UPF86420). For ROMK detection, an additional ultracentrifugation step at 100'000g for 1h was performed for membrane enrichment.
MATERIAL AND METHODS
Immunoblots were carried out and proteins quantified as previously described (45) .
Antibodies. Anti-NCC antibodies (43, 53 Immunohistochemistry. Mice were anesthetized by Ketamine/Xylazine i.p. injection.
Cardiac perfusions with PBS followed by PFA 4% were performed. Before freezing, fixed kidneys were kept in 30% sucrose in PBS solution at 4°C overnight. Immunostaining was performed on 5µ cryosections using the primary antibodies listed in the antibody section below. 
Sgk1
Pax8/LC1 mice.
RNA extraction and TaqMan® Gene Expression Assays.
Total RNA was purified from total kidneys using TRIzol (Ambion) and precipitated with isopropanol. cDNA was synthetized from 2-5 μg of total RNA using SuperScript II reverse transcriptase (Life-Technologies) and random hexamers (Promega). TaqMan Gene Expression Assays (Life Technologies) were used to analyze gene expression. Primers/probes were: Nedd4l (NEDD4-2; ThermoFisher Scientific
Statistical analysis. The significance of the metabolic parameters of the experimental groups under different diets were analyzed using Two-way ANOVA followed by Bonferroni multiple comparisons tests. Values were considered significant when α < 0.05. When involving only one factor, the data were statistically analyzed using an unpaired Student's t test. Values were considered significant when p ≤ 0.05. Data are represented as means ± standard error of the mean (sem).
RESULTS

Sgk1
Pax8/LC1 mice display suppression of SGK1 in the kidney, but not in the liver.
The present model, Sgk1 Pax8/LC1 , was described previously; recombination of genomic DNA was not only reported for the kidney, but also the liver (18), consistent with Pax8 promotor activity as reported previously (57). We therefore analyzed Sgk1 mRNA and SGK1
protein expression in the liver and compared it to the kidney ( Fig. 1) . Whereas there was recombination as seen previously in both organs (Fig. 1A ), mRNA and protein levels of SGK1
(using an anti pT256-SGK1 antibody) were not affected in the liver, whereas they were strongly reduced in the kidney ( Fig. 1B-D Pax8/LC1 versus control mice (data now shown). However, after 2 days of HKD, the cleavage product of αENaC, and both full-length and cleaved γENaC were decreased with no change in βENaC (Fig. 3A,B) ; this difference was accompanied by a decrease in αENaC apical localization and a reduction in intracellular and apical γENaC expression (Fig. 3C) (Fig. 4A,B) . Interestingly, total NEDD4-2 expression was also decreased (Fig. 4A-C (Fig. 4A,B ), but we observed important changes by immunofluorescence analysis. The stainings in control mice showed that in the DCT (co-localization with NCC), WNK1 exhibited a punctate pattern (Fig. 4D ). Such localization profile had been previously described for WNK4 (55) . On the other hand, in the CNT/CD (co-localization with AQP2) of these mice, WNK1 was homogenously diffused within the cells (Fig. 4E ). This segment-specific pattern of WNK1 may be related to differences in the signaling pathway associated to WNK1 in each segment. In contrast, in the
Pax8/LC1 mice, WNK1 in the DCT displayed a diffuse localization (Fig. 4D ). In addition, its expression was reduced in the CNT/CD compared to control littermates (Fig. 4E ). These deregulations were related to a decrease in WNK activity in both DCT and CNT/CD of mutant compared to control mice as evidenced by the reduced staining with a p382WNK1/WNK4
(Pan-pWNK) antibody, an indicator of WNK1/WNK4 activity (Fig. 5) . These data suggest that SGK1 controls NEDD4-2 phosphorylation also under HK conditions (as was the case with a low Na + diet (18)), and influences the subcellular localization/expression and activity of WNK1.
Pax8/LC1 KO mice show increased ROMK expression SGK1 had been suggested to be a positive regulator of ROMK (32, 38, 44, 66, 68, 69) .
Surprisingly, however, in the hyperkalemic Sgk1 -/-KO mice, apical localization of ROMK was increased (23). One possible explanation for this apparent contradiction might be compensatory mechanisms taking place during nephrogenesis. We generated a novel anti-ROMK antibody in guinea pigs as described in Material and Methods, and validated the antibody by Western blotting (Fig. 6A,B) . The antibody recognized transfected ROMK in HEK293 cells and in total kidney membrane extracts, whereas the corresponding bands were not visible in non-transfected cells or in kidneys from ROMK KO mice (Kcnj1 KO mice). We then analyzed ROMK in
Pax8/LC1 kidneys from mice kept under HKD and found also in this model a slight increase in the fully-glycosylated form of ROMK in Sgk1 Pax8/LC1 animals (Fig. 6C, D) .
Immunofluorescence analysis further revealed that ROMK protein abundance and membrane expression were enhanced both in the DCT and CNT/CD of Sgk1 Pax8/LC1 animals as indicate the co-localization images of ROMK with either NCC or αENaC (Fig. 6E, F) . This suggests that the hyperkalemia triggered by renal SGK1 deletion is independent of ROMK.
NCC and SPAK phosphorylation is altered in Sgk1
Pax8/LC1 mice NCC dephosphorylation under K + load has been described in several reports (42, (53) (54) (55) 58) . To analyze the response of NCC to the observed hyperkalemia in Sgk1 Pax8/LC1 mice, we analyzed NCC phosphorylation and expression both under ND and after 2 days of HKD. We found that under ND, NCC phosphorylation and expression were similar in Sgk1 Pax8/LC1 and control mice (not shown). Under HKD, NCC phosphorylation levels were much weaker in the mutant mice and no difference in total NCC expression was observed (Fig. 7A-C) . In addition, immunofluorescence analysis of kidney sections revealed that NCC was less localized to the apical membrane in the KO mice (Fig. 7C) . We then asked if this weak NCC phosphorylation correlated with changes in SPAK phosphorylation, a kinase known to phosphorylate and
activate NCC (43). SPAK is phosphorylated by WNK kinases on threonine (T233) in the Tloop of the kinase domain that is crucial for SPAK activation (2, 61). Our IF analyses revealed
that similarly to WNK1, total SPAK exhibited a punctuate pattern in the distal convoluted tubule (DCT) of control animals, which was less pronounced in Sgk1 Pax8/LC1 mice (Fig. 7D ).
Phosphorylation at T233 was reduced in the DCT as compared to control animals consistent with the reduced NCC phosphorylation (Fig. 7E) showing reduced NEDD4-2 phosphorylation on both S222 and S328 sites (18) . However, the decrease in NEDD4-2 total expression found here might be due to the hyperkalemia and/or to increased aldosterone levels. Indeed, van der Lubbe et al. had shown that NEDD4-2 expression was decreased in rats fed with HKD (59). Moreover, Loffing-Cueni et al. had described that low Na + diet caused reduction in NEDD4-2 expression, and provided evidence that it was aldosterone dependent inhibition of NEDD4-2 levels (33). Taken together, this suggests that aldosterone inhibits NEDD4-2 action via 1) SGK1-dependent phosphorylation (likely a rapid mechanism of regulation) and 2) lowering its expression by an uncharacterized posttranscriptional mechanism (slow or late mode). NEDD4-2 phosphorylation at S328 interferes with regulation of ENaC (17, 52) . Consistent with this, we observed under HKD lower expression of γENaC, as well as decreased cleavage of α-and γENaC, features that had been associated with increased ubiquitylation of ENaC (24, 27, 49, 50). Our findings are in line with previous reports showing the decrease in γENaC cleavage in Sgk1 -/-mice treated by aldosterone for 7 days (19). These Sgk1 -/-mice exhibited a Na + losing phenotype under low salt diet, but intriguingly an increase in amiloride-sensitive Na + currents, as measured by whole-cell patchclamping in the CCD. In contrast, low amiloride-sensitive transepithelial potential differences (a marker for ENaC activity) in isolated CCDs from Sgk1 -/-mice under HKD were reported by Huang et al. (23) . Similarly to the Sgk1 -/-mice, Sgk1 Pax8/LC1 did not exhibit Na + loss compared to control mice when fed HKD despite the observed decrease in α and γENaC inactivation and NCC. One possible explanation is an increase in Na + reabsorption in the proximal tubules as previously reported in Sgk1 -/-under low salt diet (65) . Interestingly, transgenic mice with specific deletion of αENaC in renal-tubules (39) 
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